TITLE

T-spot test in TB

PUB. DATE
December 2007
SOURCE
Thorax;Dec2007 Supp, Vol. 62, pA22
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts on medical topics which include the role of T cell based interferon release assays in evaluating patients with suspected active tuberculosis (TB), contact screening of TB in immunocompromised human immunodeficiency virus (HIV) positive patients and T-spot-TB reactivity after chemoprophylaxis for latent tuberculosis in HIV positive patients.
ACCESSION #
27950435

 

Related Articles

  • Tonsillar Tuberculosis and HIV Coinfection. Duijnstee, Mark L. G.; Van den Berg, Rob G. // Journal of Otolaryngology;Jun2006, Vol. 35 Issue 3, p205 

    Presents a medical case of a 35-year-old HIV-positive man with tonsillar tuberculosis. Medical examinations done to the patient; Explanation on HIV-related tuberculosis; Information on the clinical differential diagnosis of tonsil enlargement with ulcerations and white patches on a red surface.

  • Combining TB and HIV treatment to save lives.  // WHO Drug Information;2004, Vol. 18 Issue 4, p293 

    Reports on the combination of TB and HIV interventions in saving the lives of HIV infected people. Significance of joint TB and HIV treatment; Effectiveness of the combined TB and HIV interventions; Prognosis of people given with combined TB and HIV treatment that people with single treatment only.

  • IFN-Ï’ response on T-cell based analysis in HIV-infected patients for detection of tuberculosis infection. Latorre, Irene; Martínez-Lacasa, Xavier; Font, Roser; Lacoma, Alicia; Puig, Jordi; Tural, Cristina; Lite, Josep; Prat, Cristina; Cuchi, Eva; Ausina, Vicente; Domínguez, Jose // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p348 

    Background: Individuals infected with human immunodeficiency virus (HIV) have an increased risk of progression to active tuberculosis following Mycobacterium tuberculosis infection. The objective of the study was to determine IFN-γ responses for the detection of latent tuberculosis infection...

  • Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Campos, Pablo E.; Suarez, Pedro G.; Sanchez, Jorge; Zavala, David; Arevalo, Jorge; Ticona, Eduardo; Nolan, Charles M.; Hooton, Thomas M.; Holmes, King K. // Emerging Infectious Diseases;Dec2003, Vol. 9 Issue 12, p1571 

    During 1999 to 2000, we identified HIV-infected persons with new episodes of tuberculosis (TB) at 10 hospitals in Lima, Peru, and a random sample of other Lima residents with TB. Multidrug-resistant (MDR)-TB was documented in 35 (43%) of 81 HIV-positive patients and 38 (3.9%) of 965 patients...

  • Study of pulmonary involvement in HIVseropositive patients. Nair, Girija; Deshmukh, Hafiz; Jayalakshmi, T. K.; Uppe, Abhay; Modi, Kavita // BMC Infectious Diseases;2012 Supplement, Vol. 12 Issue Supplment 1, p1 

    The article presents a study on the pulmonary risks involved in HIV-seropositive patients in India. The author investigates the exposure of HIV patients to pulmonary tuberculosis secondary to HIV infection. They state that such conditions may be a major cause of morbidity and mortality among...

  • Chemoprophylaxis in tuberculosis and HIV infection. Walley, John; Porter, John // BMJ: British Medical Journal (International Edition);6/24/95, Vol. 310 Issue 6995, p1621 

    Discusses whether chemoprophylaxis with a course of antituberculous drugs, should be given to people in developing countries who are infected with mycobacterium tuberculosis and HIV, to prevent the reactivation of latent tuberculosis. Efficacy of the treatment; Cost effectiveness; Financial and...

  • Contact tracing and population screening for tuberculosis - who should be assessed? B.R. Underwood; V.L.C. White; T. Baker; M. Law; J.C. Moore-Gillon // Journal of Public Health Medicine;Mar2003, Vol. 25 Issue 1, p59 

    Background The aim of the study was to investigate the relative effectiveness of four strategies in detecting and preventing tuberculosis: contact tracing of smear-positive pulmonary disease, of smear-negative pulmonary disease and of non-pulmonary disease, and screening new entrants. Methods An...

  • Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. Mayanja-kizza, Harriet; Jones-lopez, Edward; Okwera, Alphonse; Wallis, Robert S.; Elmer, Jerrold J.; Muqerwa, Roy D.; Whalen, Christopher C.; Ellner, Jerrold J; Mugerwa, Roy D; Uganda-Case Western Research Collaboration // Journal of Infectious Diseases;3/15/2005, Vol. 191 Issue 6, p856 

    Background. Human immunodeficiency virus (HIV)-infected patients with tuberculosis (TB) respond to effective antituberculous therapy, but their prognosis remains poor. Mounting evidence from clinical studies supports the concept of copathogenesis in which immune activation that is triggered by...

  • Reinfection with Mycobacterium tuberculosis after Treatment: Canada and the United States. Deresinski, Stan // Clinical Infectious Diseases;4/1/2005, Vol. 40 Issue 7, preceding p915 

    This article focuses on reinfection with mycobacterium tuberculosis after treatment. An accurate estimate of the proportion of cases due to reinfection in Canada and the United States, where the annual incidence of TB is !6 cases per 100,000 population, has previously been lacking. The...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics